Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
ABSTRACT Pancreatic islet transplantation is a crucial treatment for managing type 1 diabetes (T1D) in clinical settings. However, the limited availability of human cadaveric islet donors and the need for ongoing administration of immunosuppressive agents post‐transplantation hinder the widespread u...
Saved in:
Main Authors: | Xue Wang, Ziyuan Zeng, Dayan Li, Kai Wang, Wei Zhang, Yang Yu, Xi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Diabetes |
Subjects: | |
Online Access: | https://doi.org/10.1111/1753-0407.70048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An unmet need: Pancreatic beta cell replacement
by: F Mohamed, et al.
Published: (2024-04-01) -
Mannogalactoglucan from mushrooms protects pancreatic islets via restoring UPR and promotes insulin secretion in T1DM mice
by: Ting Liu, et al.
Published: (2024-05-01) -
Usp7 contributes to the tail regeneration of planarians via Islet/Wnt1 axis
by: Ang Liang, et al.
Published: (2025-01-01) -
Fibronectin in Immune Responses in Organ TransplantRecipients
by: Ana J. Coito, et al.
Published: (2000-01-01) -
Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance
by: Ji Won Han, et al.
Published: (2024-12-01)